dabigatran has been researched along with Wet Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akter, T; Annamalai, B; Obert, E; Rohrer, B; Simpson, KN | 1 |
1 other study(ies) available for dabigatran and Wet Macular Degeneration
| Article | Year |
|---|---|
Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base.
Topics: Animals; Choroidal Neovascularization; Dabigatran; Disease Models, Animal; Epithelial Cells; Medicare; Mice; Retinal Pigments; Thrombin; United States; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2022 |